NEWS

LIPIGON PRESS RELEASES AND NEWS
  • combigene.jpg

    2019-10-11

    “We are very happy to enter this agreement with CombiGene ,” says Stefan K Nilsson, CEO at Lipigon

  • defaultnews.jpg

    2018-05-28

    CARINA SCHMIDT IS ANNOUNCED NEW CHAIRPERSON OF THE BOARD

    Carina Schmidt has been appointed as the Chairperson of Lipigon Pharmaceuticals, she succeeds Gisela Sitbon.

  • 2017-12-10

    LIPIGON CEO AND CO-FOUNDER STEFAN K NILSSON HAS BEEN ELECTED COMMITTEE MEMBER OF PRESTIGOUS EUROPEAN LIPOPROTEIN CLUB

    The European Lipoprotein Club (ELC) is the oldest and most active European meeting in the field of lipids.

  • 2017-10-11

    LIPIGON PHARMACEUTICALS ENTERS INTO TARGET VALIDATION RESEARCH AGREEMENT WITH GERMAN ANTISENSE COMPANY SECARNA PHARMACEUTICALS

    Lipigon Pharmaceuticals (“Lipigon”) announced today that it has entered into a Target Validation Research Agreement with Munich-based antisense therapeutics company Secarna Pharmaceuticals (“Secarna”).

  • 2017-09-25

    LIPIGON HAS BEEN NOMINATED AS UNIVERSITY SPIN-OUT OF THE YEAR

    Lipigon is nominated as this year’s spin-out company at UmeåGalan2017.

  • 2017-04-05

    LIPIGON PHARMACEUTICALS ANNOUNCES THE APPOINTMENT OF A NEW CHAIRMAN OF THE BOARD

    Effective immediately Lipigon is announcing Dr. Gisela Sitbon as new Chairman of the Board.

  • 2016-12-27

    LIPIGON PHARMACEUTICALS JOINS ASTRAZENECA’S BIOVENTURHUB

    Starting December 2016 Lipigon joins the AZ BioVentureHub located at AstraZeneca’s site in Mölndal, Sweden.

  • 2016-12-20

    LIPIGON WELCOMES NEW INVESTORS AND PARTNERS

    Lipigon is happy to announce 3 new major partners investing in the company.

  • 2016-06-30

    LIPIGON CEO STEFAN K. NILSSON IN INTERVIEW AS INVITED SPEAKER FOR BIOFIT 2016

    Lipigon CEO Stefan K. Nilsson is an invited speaker at BioFIT 2016 in Lille, France.

  • 2016-03-30

    MIKAEL ELOFSSON INTERVIEWED AT ADD 2016

    Lipigon board member Prof. Mikael Elofsson interviewed at ADD 2016

  • 2016-03-14

    LIPIGON PHARMACEUTICALS AND ASTRAZENECA ENTER DRUG DISCOVERY COLLABORATION

    Lipigon Pharmaceuticals today announced that it has entered into a research collaboration with AstraZeneca.

  • 2016-03-02

    AVAILABLE POSITIONS

    Lipigon is expanding and looking for new talents to join our team.

  • 2016-02-04

    LIPIGON AWARDED CONNECT´S PITCH PRIZE

    Lipigon awarded Connect´s pitch prize at Biotech Umeå investment Day

  • 2015-12-10

    LIPIGON PATENT APPLICATION PUBLISHED

    Lipigon’s first patent application “New plasma lipid lowering agents”...

  • 2015-09-02

    LIPIGON SCIENTISTS PUBLISH IN PRESTIGIOUS JOURNAL

    Lipigon scientists publish SAR relationship in Eur J Med Chem.

  • 2015-05-02

    LIPIGON CEO TO FRONT NATIONAL SSMF CAMPAIGN

    CEO Stefan K Nilsson is one of out of five promising young scientists that has been selected to front the Swedish Society for Medical Research’s fund raising campaign.

  • 2014-11-18

    LIPIGON SIGNS DEAL WITH ASTRAZENECA

    Lipigon Pharmaceuticals and AstraZeneca enter research collaboration to develop a high throughput assay for the identification of molecules that modulate lipoprotein lipase activity.

  • 2014-09-05

    LIPIGON CEO STEFAN K NILSSON RECEIVES SSMF POSTDOCTORAL AWARD

    Lipigon CEO Dr. Stefan K Nilsson has been awarded the Swedish Society for Medical Research postdoctoral support.

  • 2014-06-28

    LIPIGON SCIENTISTS IDENTIFIES LPL ACTIVATORS

    Lipigon scientists publish results for first LPL activators

  • 2014-01-27

    LIPIGON ATTENDS: BIOTECH UMEÅ INVESTMENT DAY

    Lipigon attends: Biotech Umeå investment Day at Grand Hotel Stockholm.

  • 2014-01-18

    LIPIGON ATTENDS: SWISS-SWEDEN

    Lipigon attends: Swiss-Sweden